Black Hawk Acquisition Corp. Files Proxy Statement Amendment

Ticker: BKHAR · Form: DEFA14A · Filed: Jul 8, 2025 · CIK: 2000775

Black Hawk Acquisition CORP DEFA14A Filing Summary
FieldDetail
CompanyBlack Hawk Acquisition CORP (BKHAR)
Form TypeDEFA14A
Filed DateJul 8, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: proxy-statement, shareholder-meeting, amendment

TL;DR

BHAC filed proxy docs, shareholders need to pay attention for upcoming votes.

AI Summary

Black Hawk Acquisition Corp. filed Amendment No. 1 to its definitive proxy statement on June 10, 2025. This filing is related to a shareholder meeting and is classified as a DEFA14A, indicating it's a proxy statement for soliciting shareholder votes. The company operates in the Biological Products sector.

Why It Matters

This filing is crucial for shareholders as it contains important information regarding upcoming votes and corporate actions that could impact their investment in Black Hawk Acquisition Corp.

Risk Assessment

Risk Level: low — The filing is a standard proxy statement amendment, not indicating immediate financial distress or significant new risks.

Key Players & Entities

FAQ

What is the purpose of a DEFA14A filing?

A DEFA14A filing is a definitive proxy statement filed with the SEC, used to solicit shareholder votes on specific matters, such as annual meetings or corporate actions.

When was Amendment No. 1 to the definitive proxy statement filed?

Amendment No. 1 to the definitive proxy statement was filed on June 10, 2025.

What is the primary business of Black Hawk Acquisition Corp. according to the filing?

According to the filing, Black Hawk Acquisition Corp. is in the Biological Products sector, specifically Biological Products (No Diagnostic Substances) [2836].

What is the filing date of the DEFA14A document?

The filing date of the DEFA14A document is July 8, 2025.

What is the SIC code associated with Black Hawk Acquisition Corp.?

The Standard Industrial Classification (SIC) code associated with Black Hawk Acquisition Corp. is 2836, which corresponds to Biological Products (No Diagnostic Substances).

Filing Details

This Form DEFA14A (Form DEFA14A) was filed with the SEC on July 8, 2025 regarding Black Hawk Acquisition Corp (BKHAR).

View full filing on EDGAR

View Full Filing

View this DEFA14A filing on SEC EDGAR

View on Read The Filing